Definition
It is the covalent modification of a protein by conjugation to ubiquitin (Fig. 1). Ubiquitin is a small, 76-residue protein found in all eukaryotes. Conjugates are formed through the ligation of the C-terminus of ubiquitin to the ε-amino groups of protein lysine residues. The major, but not sole, function of ubiquitination is to target proteins for degradation by the proteasome. A large number of proteins are substrates for this regulatory pathway. Efficient targeting of proteins for degradation usually involves formation of a multiubiquitin chain on the target protein. Such chains are characterized by specific ubiquitin-ubiquitin linkages.
References
Boisvert RA, Howlett NG (2014) The fanconi anemia ID2 complex: Dueling saxes at the crossroads. Cell Cycle 13(19):2999–3015. doi:10.4161/15384101.2014.956475
Curr Opin Hematol (2015) The role of aberrant proteolysis in lymphomagenesis. 22(4):369–78. doi:10.1097/MOH.0000000000000156
de Thé H (2015) Lessons taught by acute promyelocytic leukemia cure. Lancet 386(9990):247–248. doi:10.1016/S0140-6736(15)61278-8
Deshaies RJ (2014) Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy. BMC Biol 12:94
Elledge SJ, Harper JW (1998) The role of protein stability in the cell cycle and cancer. Biochim Biophys Acta 1377:M61–M70
Fink EC, Ebert BL (2015) The novel mechanism of lenalidomide activity. Blood 126(21):2366–2369
Heo J, Eki R, Abbas T (2016) Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis. Semin Cancer Biol 36:33–51
Massoumi R, Paus R (2007) Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control. Bioessays 29:1203–1214
Popovic D, Vucic D, Dikic I (2014) Ubiquitination in disease pathogenesis and treatment. Nat Med 20(11):1242–1253
Rubin DM, Finley D (1995) The proteasome: a protein-degrading organelle? Curr Biol 5:854–858
Sahasrabuddhe AA, Elenitoba-Johnson KS (2015) The role of aberrant proteolysis in lymphomagenesis. Curr Opin Hematol 22(4):369–378. doi:10.1097/MOH.0000000000000156
See Also
(2012) Benign Tumor. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 381. doi:10.1007/978-3-642-16483-5_579
(2012) CYLD. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1036. doi:10.1007/978-3-642-16483-5_1442
(2012) De-ubiquitinating Enzymes. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1104. doi:10.1007/978-3-642-16483-5_1593
(2012) FOS. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1446. doi:10.1007/978-3-642-16483-5_2252
(2012) Glycogen Synthase Kinase-3. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1570. doi:10.1007/978-3-642-16483-5_2448
(2012) JUN. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1929. doi:10.1007/978-3-642-16483-5_3186
(2012) P53. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2747. doi:10.1007/978-3-642-16483-5_4331
(2012) Ubiquitin. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3825. doi:10.1007/978-3-642-16483-5_6083
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Finley, D. (2014). Ubiquitination. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_6087-2
Download citation
DOI: https://doi.org/10.1007/978-3-642-27841-9_6087-2
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27841-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences